Data / Form D filings / Salish Bioscience Inc.
Salish Bioscience Inc.: Form D filing
Salish Bioscience Inc., a health care company in Seattle, WA, filed a Form D with the SEC in 2022. The latest, on April 14, 2022, reports $7 million sold of a $7 million offering to 25 investors.
Find out what Salish Bioscience Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3005 1st Avenue Suite 204, Seattle, WA, 98121
- Phone
- (206) 849-6038
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Washington
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1922451
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | New notice | $7,037,397 | $7,037,397 | $0 | 25 | Mar 31, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frank Paganelli | Executive Officer, Director | |
| Chris Raymond | Director | |
| Kira Misura | Director | |
| Fenella Raymond | Executive Officer, Director |
Other health care companies in Washington that filed recently
- Seattle Neurosound Solutions, Inc. $100,000 · Sep 22, 2026
- DexCare, Inc. $12.9 million · Sep 14, 2026
Every Form D from the week of Apr 11, 2022 · All recent filings in Washington · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what Salish Bioscience Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.